HENDERSON, Nev.--(BUSINESS WIRE)--3PEA International, Inc. (OTCBB:TPNL), a vertically integrated leader in tokenized payment processing focusing on the creation and implementation of innovative prepaid card programs for corporate, consumer and government applications, today announced the successful implementation of its PaySign® prepaid solution for The Interstate Companies, Inc. All 23 Interstate plasma donation centers are live and utilizing the PaySign® prepaid solution as their exclusive donor payment method.
“We are confident and comfortable to have 3PEA as our payment solution provider. 3PEA took the time to understand our needs and delivered the comprehensive payment and data solutions we envisioned,” said Lenny Goodman, Director of Information Technologies at The Interstate Companies. “Throughout the entire process, from program conception to development to implementation, 3PEA’s level of responsiveness, quality of work and attention to detail went far beyond our expectations. Since the beginning of implementation in early September, we have experienced a significant increase in card payment program uptime, allowing us to process our donors more efficiently. Everyone at The Interstate Companies, from Accounting, Operations, Information Technology to center operators and managers are extremely happy with 3PEA and the customized PaySign® prepaid solution they have provided. Most importantly, the feedback from the donors has been exceptionally positive.”
3PEA delivered the comprehensive PaySign® prepaid solution, which includes the “PaySign Connect,” an intuitive, easy-to-use, fully tokenized platform tailored to the unique requirements of the plasma collection industry. The PaySign Connect portal can run as either a standalone, web-based solution or can be fully integrated with existing donor management systems. The PaySign Connect portal securely stores donor information and donation history, including volume range, weight group, donor type, donation frequency, notes, and other pertinent fields. 3PEA’s customized reports simplify accounting procedures, reduce administrative costs, streamline operations, increase efficiency, and help maintain compliance requirements. Adding a dimension far beyond simple financial accounting and funds reconciliation, the PaySign® solution provides a level of business analytics previously unavailable from existing payment card programs.
The PaySign prepaid solution also includes the PaySign® Interstate Visa® Prepaid Card that can be used anywhere Visa is accepted. Plasma donors can access their account information using the PaySign kiosk located at any Interstate donation center, a dedicated cardholder website, an Interactive Voice Response (IVR) system, SMS alerts, two-way SMS, or by calling 3PEA’s in-house bilingual customer service center, staffed 24/7/365. The customized PaySign prepaid solution was built with the goals of improving donor retention rates and overall donor satisfaction.
“3PEA is pleased to be providing our customized PaySign® Connect portal and prepaid card solution to The Interstate Companies,” said Mark Newcomer, Chairman and CEO of 3PEA International. “As we continue to gain market share in this rapidly growing industry, 3PEA is committed to maintaining the highest standards of quality and service, the cornerstone of our business. We look forward to a long and successful relationship with The Interstate Companies and their donors.”
About 3PEA International
3PEA International (OTCBB:TPNL) is an experienced and trusted prepaid debit card payment solutions provider as well as an integrated payment processor that has millions of prepaid debit cards in its portfolio. Through its PaySign brand, 3PEA designs and develops payment solutions, prepaid card programs, and customized payment services. 3PEA manages programs for many of the world’s largest pharmaceutical manufacturers with copay assistance products designed to maximize new patient acquisition, retention, and adherence. 3PEA’s corporate incentive prepaid cards are changing the way corporations reward, motivate, and engage their current and potential customers, employees, and agents. 3PEA’s customizable prepaid solutions offer significant cost savings while improving brand recognition and customer loyalty. 3PEA’s customers include healthcare companies, major pharmaceutical companies and source plasma providers, large multinationals, prestigious universities, and social media companies. PaySign is a registered trademark of 3PEA Technologies, Inc. in the United States and other countries. For more information visit us at www.3pea.com or follow us on Twitter and Facebook.
About The Interstate Companies
The Interstate Companies is a group of nine Whole Blood centers, twenty-three plasmapheresis centers, and a laboratory which provide human blood and/or blood components to the therapeutic and diagnostic industries. The Interstate Companies has been in the Whole Blood and Plasmapheresis business since 1949. The Company has locations in fourteen states with Corporate Headquarters in Memphis, Tennessee. The Interstate Companies was one of the founding firms of American Blood Resources Association (ABRA), now Plasma Protein Therapeutics Association (PPTA). At least one the Company’s corporate officers has served on its board of directors since its inception in 1971. The Interstate Companies’ customer base consists of leading manufacturers and innovators of research and development in the medical and scientific industries, not only on a national level, but in the international market as well. The Company is licensed and audited by the U.S. Food and Drug Administration (FDA). Each of the Company’s plasmapheresis centers are IQPP (International Quality Plasma Program) certified. For more information visit us at www.interstatebloodbank.com.
Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the companies, are forward-looking statements that involve risks and uncertainties. There is no assurance that such statements will prove to be accurate, and actual results and future events could differ materially. 3PEA undertakes no obligation to publicly update or revise any statements in this release, whether as a result of new information, future events, or otherwise.